Surgical management of hepatic malignancy

Cancer Investigation

Volumn 22, Issue 2, 2004, Pages 283-303

  Kooby, David A ^a   Jarnagin, William R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Carcinoma; Colorectal neoplasm; Hepatectomy; Hepatocellular; Liver neoplasm

Indexed keywords

BILE DUCT CANCER; BLEEDING; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; COLORECTAL TUMOR; HUMAN; LENGTH OF STAY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MINIMALLY INVASIVE SURGERY; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SAFETY; SHORT SURVEY; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 2642558870     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120030217     Document Type: Short Survey

References (159)

1. Lau, W. Primary heptocellular carcinoma. In Surgery of the Liver and Biliary Tract; Blumgart, L.H., Fong, Y., Eds.; Saunders: London, UK, 2002; 1423-1450.
2. Fong, Y. Surgical therapy of hepatic colorectal metastasis. CA. Cancer J. Clin. 1999, 49 (4), 231-255.
3. Beck, C. Surgery of the liver. JAMA 1902, 78, 1063-1068.
4. Langenbuch, D. Ein fall von resektion eines linksseitigen schnurlappens der leber. Heilung Berl. Klin. Wochenschr. 1888, 25, 37-38.
5. Tiffany, L.M. The removal of a solid tumor from the liver by laparotomy. Md. Med. J. 1890, 23, 531.
6. Glisson, F. Anatomia Hepatis; O Pullein: London, 1654.
7. Cantlie, J. On a new arrangement of the right and left lobes of the liver. J. Anat. Physiol. 1897, 32, 4-9.
8. Couinaud, C. Etudes Anatomique Et Chirurgales; Mason: Paris, 1954.
9. Goldsmith, N.; Woodburne, R. The surgical anatomy pertaining to liver resection. Surg. Gynecol. Obstet. 1957, 105, 310-318.
10. Pringle, J. Notes on the arrest of hepatic hemorrhage due to trauma. Ann. Surg. 1908, 48, 541.
11. Lortat-Jacob, R. Hepatectomy droite reglee. Presse Med. 1952, 60, 549-551.
12. Foster, J.H.; Berman, M.M. Solid liver tumors. Major Probl. Clin. Surg. 1977, 22, 1-342.
13. Fan, S.T.; Lo, C.M.; Liu, C.L.; Lam, C.M.; Yuen, W.K.; Yeung, C.; Wong, J. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann. Surg. 1999, 229 (3), 322-330.
14. Fong, Y.; Fortner, J.; Sun, R.L.; Brennan, M.F.; Blumgart, L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 1999, 230 (3), 309-318.
15. Gayowski, T.J.; Iwatsuki, S.; Madariaga, J.R.; Selby, R.; Todo, S.; Irish, W.; Starzl, T.E. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994, 116 (4), 703-710.
16. Nordlinger, B.; Guiguet, M.; Vaillant, J.C.; Balladur, P.; Boudjema, K.; Bachellier, P.; Jaeck, D. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996, 77 (7), 1254-1262.
17. Blumgart, L.H.; Hann, L.E. Surgical and radiologic anatomy of the liver and biliary tract. In Surgery of the Liver and Biliary Tract; Blumgart, L.H., Fong, Y., Eds.; Saunders: London, UK, 2000; 3-33.
18. Bismuth, H.; Castaing, D.; Garden, O.J. The use of operative ultrasound in surgery of primary liver tumors. World J. Surg. 1987, 11 (5), 610-614.
19. Parker, G.A.; Lawrence, W., Jr.; Horsley, J.S., III; Neifeld, J.P.; Cook, D.; Walsh, J.; Brewer, W.; Koretz, M.J. Intraoperative ultrasound of the liver affects operative decision making. Ann. Surg. 1989, 209 (5), 569-576.
20. Staren, E.D.; Gambla, M.; Deziel, D.J.; Velasco, J.; Saclarides, T.J.; Millikan, K.; Doolas, A. Intraoperative ultrasound in the management of liver neoplasms. Am. Surg. 1997, 63 (7), 591-596.
21. Jarnagin, W.R.; Bach, A.M.; Winston, C.B.; Hann, L.E., Heffernan, N.; Loumeau, T.; DeMatteo, R.P.; Fong, Y.; Blumgart, L.H. What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease? J. Am. Coll. Surg. 2001, 192 (5), 577-583.
22. Scheele, J. Segment-oriented resection of the liver: rationale and technique. In Hepatobiliary and Pancreatic Malignancies: Diagnosis, Medical and Surgical Therapy; Lygidakis, N., Tytgat, G., van der Heyde, M., et al., Eds.; Thieme: Stuttgart, 1989; 219-246.
23. DeMatteo, R.P.; Palese, C.; Jarnagin, W.R.; Sun, R.L.; Blumgart, L.H.; Fong, Y. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J. Gastrointest. Surg. 2000, 4 (2), 178-184.
24. Blumgart, L.H.; Fong, Y. Liver resection for benign disease and for liver and biliary tumors. In Surgery of the Liver anti Biliary Tract; Blumgart, L.H., Fong, Y., Eds.; Harcourt: London, 2000; 1639-1714.
25. Lo, C.M.; Lai, E.C.; Liu, C.L.; Fan, S.T.; Wong, J. Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma. Ann. Surg. 1998, 227 (4), 527-532.
26. Callery, M.P.; Strasberg, S.M.; Doherty, G.M.; Soper, N.J.; Norton, J.A. Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy. J. Am. Coll. Surg. 1997, 185 (1), 33-39.
27. Jarnagin, W.R.; Bodniewicz, J.; Dougherty, E.; Conlon, K.; Blumgart, L.H.; Fong, Y. A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies. J. Gastrointest. Surg. 2000, 4 (1), 34-43.
28. Marks, J.; Mouiel, J.; Katkhouda, N.; Gugenheim, J.; Fabiani, P. Laparoscopic liver surgery. A report on 28 patients. Surg. Endosc. 1998, 12 (4), 331-334.
29. Fong, Y.; Jarnagin, W.; Conlon, K.C.; Dematteo, R.; Dougherty, E.; Blumgart, L.H. Hand-assisted laparoscopic liver resection: lessons from an initial experience. Arch. Surg. 2000, 135 (7), 854-859.
30. Antonetti, M.C.; Killelea, B.; Orlando, R., III. Hand-assisted laparoscopic liver surgery. Arch. Surg. 2002, 137 (4), 407-411.
31. Little, J.M.; Hollands, M.J. Impact of the CUSA and operative ultrasound on hepatic resection. HPB Surg. 1991, 3 (4), 271-277.
32. Gertsch, P.; Pelloni, A.; Guerra, A.; Krpo, A, Initial experience with the harmonic scalpel in liver surgery. Hepatogastroenterology 2000, 47 (33), 763-766.
33. Baer, H.U.; Stain, S.C.; Guastella, T.; Maddern, G.J.; Blumgart, L.H. Hepatic resection using a water jet dissector. HPB Surg. 1993, 6 (3), 189-196.
34. Izumi, R.; Yabushita, K.; Shimizu, K.; Yagi, M.; Yamaguchi, A.; Konishi, K.; Nagakawa, T.; Miyazaki, I. Hepatic resection using a water jet dissector. Surg. Today 1993, 23 (1), 31-35.
35. Fong, Y.; Blumgart, L.H. Useful stapling techniques in liver surgery. J. Am. Coll. Surg. 1997, 185 (1), 93-100.
36. Matthews, B.D.; Pratt, B.L.; Backus, C.L.; Kercher, K.W.; Mostafa, G.; Lentzner, A.; Lipford, E.H.; Sing, R.F.; Heniford, B.T. Effectiveness of the ultrasonic coagulating shears, LigaSure vessel sealer, and surgical clip application in biliary surgery: a comparative analysis. Am. Surg. 2001, 67 (9), 901-906.
37. Horgan, P.G. A novel technique for parenchymal division during hepatectomy. Am. J. Surg. 2001, 181 (3), 236-237.
38. Jarnagin, W.R.; Gonen, M.; Fong, Y.; DeMatteo, R.P.; Ben-Porat, L.; Little, S.A.; Corvera, C.; Weber, S.; Blumgart, L.H. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann. Surg. 2002, 236 (4), 397-407.
39. Man, K.; Fan, S.T.; Ng, I.O.; Lo, C.M.; Liu, C.L.; Wong, J. Prospective evaluation of pringle maeuver in hepatectomy for liver tumors by a randomized study. Ann. Surg. 1997, 226 (6), 704-711.
40. Heaney, J.P.; Stanton, W.K.; Halbert, D.S.; Seidel, J.; Vice, T. An improved technic for vascular isolation of the liver: experimental study and case reports. Ann. Surg. 1966, 163 (2), 237-241.
41. Emre, S.; Schwartz, M.E.; Katz, E.; Miller, C.M. Liver resection under total vascular isolation. Variations on a theme. Ann. Surg. 1993, 217 (1), 15-19.
42. Bismuth, H.; Castaing, D.; Garden, O.J. Major hepatic resection under total vascular exclusion. Ann. Surg. 1989, 210 (1), 13-19.
43. Cunningham, J.D.; Fong, Y.; Shriver, C.; Melendez, J.; Marx, W.L.; Blumgart, L.H. One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch. Surg. 1994, 129 (10), 1050-1056.
44. Melendez, J.A.; Arslan, V.; Fischer, M.E.; Wuest, D.; Jarnagin, W.R.; Fong, Y.; Blumgart, L.H. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J. Am. Coll. Surg. 1998, 187 (6), 620-625.
45. Belghiti, J.; Noun, R.; Zante, E.; Ballet, T.; Sauvanet, A. Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann. Surg. 1996, 224 (2), 155-161.
46. Bulfinch's Mythology; Bulfinch, T., Martin, R., Eds.; Random House: New York, 1998.
47. Pack, G.; Islami, A.Hubbard, J.; Brasfield, R. Regeneration of human liver after major hepatectomy. Surgery 1962, 52, 617-623.
48. Fausto, N. Hepatic regeneration. In Hepatology; Zakim, D., Boyer, T., Eds.; Saunders: Philadelphia, 1996; 32-57.
49. Blumgart, L.H.; Leach, K.G.; Karran, S.J. Observations on liver regeneration after right hepatic lobectomy. Gut 1971, 12 (11), 922-928.
50. Taylor, I.; Blumgart, L.H. Right hemihepatectomy for extensive liver injury. Br. J. Clin. Pract. 1971, 25 (2), 81-84.
51. Fong, Y.; Sun, R.L.; Jarnagin, W.; Blumgart, L.H. An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann. Surg. 1999, 229 (6), 790-799.
52. Matsumata, T.; Kanematsu, T.; Yoshida, Y.; Furuta, T.; Yanaga, K.; Sugimachi, K. The indocyanine green test enables prediction of postoperative complications after hepatic resection. World J. Surg. 1987, 11 (5), 678-681.
53. Hemming, A.W.; Scudamore, C.H.; Shackleton, C.R.; Pudek, M.; Erb, S.R. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am. J. Surg. 1992, 163 (5), 515-518.
54. Yamanaka, N.; Okamoto, E.; Toyosaka, A.; Mitunobu, M.; Fujihara, S.; Kato, T.; Fujimoto, J.; Oriyama, T.; Furukawa, K.; Kawamura, E. Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 1990, 65 (5), 1104-1110.
55. Lau, H.; Man, K.; Fan, S.T.; Yu, W.C.; Lo, C.M.; Wong, J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br. J. Surg. 1997, 84 (9), 1255-1259.
56. Fan, S.T.; Lai, E.C.; Lo, C.M.; Ng, I.O.; Wong, J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch. Surg. 1995, 130 (2), 198-203.
57. Child, C.; Turcotte, J. Surgery and portal hypertension. In The Liver and Portal Hypertension; Child, C., Ed.; Saunders: Philadelphia, 1964; 50-62.
58. Pugh, R.N.; Murray-Lyon, I.M.; Dawson, J.L.; Pietroni, M.C.; Williams, R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973, 60 (8), 646-649.
59. Bruix, J.; Llovet, J.M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002, 35 (3), 519-524.
60. Kinoshita, H.; Sakai, K.; Hirohashi, K.; Igawa, S.; Yamasaki, O.; Kubo, S. Preoperative portal vein embolization for hepatocellular carcinoma. World J. Surg. 1986, 10 (5), 803-808.
61. Lee, K.C.; Kinoshita, H.; Hirohashi, K.; Kubo, S.; Iwasa, R. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J. Surg. 1993, 17 (1), 109-115.
62. Kawasaki, S.; Makuuchi, M.; Kakazu, T.; Miyagawa, S.; Takayama, T.; Kosuge, T.; Sugihara, K.; Moriya, Y. Resection for multiple metastatic liver tumors after portal embolization. Surgery 1994, 115 (6), 674-677.
63. Abdalla, E.K.; Hicks, M.E.; Vauthey, J.N. Portal vein embolization: rationale, technique and future prospects. Br. J. Surg. 2001, 88 (2), 165-175.
64. Wakabayashi, H.; Ishimura, K.; Okano, K.; Karasawa, Y.; Goda, F.; Maeba, T.; Maeta, H. Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma. Surgery 2002, 131 (1), 26-33.
65. Wayne, J.D.; Lauwers, G.Y.; Ikai, I.; Doherty, D.A.; Belghiti, J.; Yamaoka, Y.; Regimbeau, J.M.; Nagorney, D.M.; Do, K.A.; Ellis, L.M.; Curley, S.A.; Pollock, R.E.; Vauthey, J.N. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann. Surg. 2002, 235 (5), 722-730.
66. Elias, D.; Ouellet, J.F.; De Baere, T.; Lasser, P.; Roche, A. Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery 2002, 131 (3), 294-299.
67. Wernecke, K.; Rummeny, E.; Bongartz, G.; Vassallo, P.; Kivelitz, D.; Wiesmann, W.; Peters, P.E.; Reers, B.; Reiser, M.; Pircher, W. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. Am. J. Roentgenol. 1991, 157 (4), 731-739.
68. Arakawa, A.; Nishiharu, T.; Matsukawa, T.; Urata, J.; Hatanaka, Y.; Yamashita, Y.; Takahashi, M.; Kanemitsu, K.; Mihara, M. Detection of hepatocellular carcinoma by intraarterially enhanced ultrasonography with CO2 microbubbles. Comparison with DSA, dynamic CT, and lipiodol CT. Acta Radiol. 1996, 37 (3 Pt. 1), 250-254.
69. Hashimoto, M.; Watanabe, O.; Hirano, Y.; Kato, K.; Watarai, J, Use of carbon dioxide microbubble-enhanced sonographic angiography for transcatheter arterial chemoembolization of hepatocellular carcinoma. Am. J. Roentgenol. 1997, 169 (5), 1307-1310.
70. Numata, K.; Tanaka, K.; Kiba, T.; Salto, S.; Isozaki, T.; Hara, K.; Morimoto, M.; Sekihara, H.; Yonezawa, H.; Kubota, T. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma. Am. J. Roentgenol. 2001, 176 (5), 1199-1205.
71. Sheafor, D.H.; Killius, J.S.; Paulson, E.K.; DeLong, D.M.; Foti, A.M.; Nelson, R.C. Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases? Radiology 2000, 214 (3), 875-880.
72. Sheafor, D.H.; Frederick, M.G.; Paulson, E.K.; Keogan, M.T.; DeLong, D.M.; Nelson, R.C. Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma. Am. J. Roentgenol. 1999, 172 (4), 961-968.
73. Kim, T.; Murakami, T.; Takahashi, S.; Tsuda, K.; Tomoda, K.; Narumi, Y.; Oi, H.; Sakon, M.; Nakamura, H. Optimal phases of dynamic CT for detecting hepatocellular carcinoma: evaluation of unenhanced and triple-phase images. Abdom. Imaging 1999, 24 (5), 473-480.
74. Valls, C.; Andia, E.; Sanchez, A.; Guma, A.; Figueras, J.; Torras, J.; Serrano, T. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology 2001, 218 (1), 55-60.
75. Rummeny, E.J.; Marchal, G. Liver imaging. Clinical applications and future perspectives. Acta Radiol. 1997, 38 (4 Pt. 2), 626-630.
76. Kuszyk, B.S.; Bluemke, D.A.; Urban, B.A.; Choti, M.A.; Hruban, R.H.; Sitzmann, J.V.; Fishman, E.K. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. Am. J. Roentgenol. 1996, 166 (1), 91-95.
77. Heiken, J.P.; Brink, J.A.; Sagel, S.S. Helical CT: abdominal applications. Radiographics 1994, 14 (4), 919-924.
78. Soyer, P.; Levesque, M.; Caudron, C.; Elias, D.; Zeitoun, G.; Roche, A. MRI of liver metastases from colorectal cancer vs. CT during arterial portography. J. Comput. Assist. Tomogr. 1993, 17 (1), 67-74.
79. Ferrucci, J. MR imaging of the liver. Am. J. Roentgenol. 1986, 147, 1103.
80. Rummeny, E.J.; Torres, C.G.; Kurdziel, J.C.; Nilsen, G.; Op, D.B.; Lundby, B. MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies. Acta Radiol. 1997, 38 (4 Pt. 2), 638-642.
81. Kim, S.K.; Kim, S.H.; Lee, W.J.; Kim, H.; Seo, J.W.; Choi, D.; Lim, H.K. ; Lee, S.J.; Lim, J.H. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging. Am. J. Roentgenol. 2002, 179 (3), 741-750.
82. Burt, B.M.; Humm, J.L.; Kooby, D.A.; Squire, O.D.; Mastorides, S.; Larson, S.M.; Fong, Y. Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia (N.Y.) 2001, 3 (3), 189-195.
83. Ruers, T.J.; Langenhoff, B.S.; Neeleman, N.; Jager, G.J.; Strijk, S.; Wobbes, T.; Corstens, F.H.; Oyen, W.J. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J. Clin. Oncol. 2002, 20 (2), 388-395.
84. Fong, Y.; Saldinger, P.F.; Akhurst, T.; Macapinlac, H.; Yeung, H.; Finn, R.D.; Cohen, A.; Kemeny, N.; Blumgart, L.H.; Larson, S.M. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am. J. Surg. 1999, 178 (4), 282-287.
85. Khan, M.A.; Combs, C.S.; Brunt, E.M.; Lowe, V.J.; Wolverson, M.K.; Solomon, H.; Collins, B.T.; Di Bisceglie, A.M. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J. Hepatol. 2000, 32 (5), 792-797.
86. Shiomi, S.; Nishiguchi, S.; Ishizu, H.; Iwata, Y.; Sasaki, N.; Tamori, A.; Habu, D.; Takeda, T.; Kubo, S.; Ochi, H. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am. J. Gastroenterol. 2001, 96 (6), 1877-1880.
87. Eubank, W.B.; Mankoff, D.A.; Schmiedl, U.P.; Winter, T.C., III; Fisher, E.R.; Olshen, A.B.; Graham, M.M.; Eary, J.F. Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy. Am. J. Roentgenol. 1998, 171 (4), 1103-1110.
88. Akhurst, T.; Chisin, R. Hybrid PET/CT machines: optimized PET machines for the new millennium? J. Nucl. Med. 2000, 41 (5), 961-963.
89. Povoski, S.P.; Fong, Y.; Sgouros, S.C.; Kemeny, N.E.; Downey, R.J.; Blumgart, L.H. Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases. Ann. Surg. Oncol. 1998, 5 (1), 9-15.
90. Fortner, J.G.; Lincer, R.M. Hepatic resection in the elderly. Ann. Surg. 1990, 211 (2), 141-145.
91. Doci, R.; Gennari, L.; Bignami, P.; Montalto, F.; Morabito, A.; Bozzetti, F. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br. J. Surg. 1991, 78 (7), 797-801.
92. Fong, Y.; Blumgart, L.H.; Fortner, J.G.; Brennan, M.F. Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann. Surg. 1995, 222 (4), 426-434.
93. DeMatteo, R.P.; Fong, Y.; Blumgart, L.H. Surgical treatment of malignant liver tumours. Best Pract. Res., Clin. Gastroenterol. 1999, 13 (4), 557-574.
94. Bengmark, S.; Hafstrom, L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969, 23 (1), 198-202.
95. Wood, C.B.; Gillis, C.R.; Blumgart, L.H. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin. Oncol. 1976, 2 (3), 285-288.
96. Willett, C.G.; Tepper, J.E.; Cohen, A.M.; Orlow, E.; Welch, C.E. Failure patterns following curative resection of colonic carcinoma. Ann. Surg. 1984, 200 (6), 685-690.
97. Saltz, L.B.; Cox, J.V.; Blanke, C.; Rosen, L.S.; Fehrenbacher, L.; Moore, M.J.; Maroun, J.A.; Ackland, S.P.; Locker, P.K.; Pirotta, N.; Elfring, G.L.; Miller, L.L. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N. Engl. J. Med. 2000, 343 (13), 905-914.
98. Scheele, J.; Stang, R.; Altendorf-Hofmann, A.; Paul, M. Resection of colorectal liver metastases. World J. Surg. 1995, 19 (1), 59-71.
99. Jamison, R.L.; Donohue, J.H.; Nagorney, D.M.; Rosen, C.B.; Harmsen, W.S. ; Ilstrup, D.M. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch. Surg. 1997, 132 (5), 505-510.
100. D'Angelica, M.; Brennan, M.F.; Fortner, J.G.; Cohen, A.M.; Blumgart, L.H.; Fong, Y. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J. Am. Coll. Surg. 1997, 185 (6), 554-559.
101. Geoghegan, J.G.; Scheele, J. Treatment of colorectal liver metastases. Br. J. Surg. 1999, 86 (2), 158-169.
102. Jaeck, D.; Bachellier, P.; Guiguet, M.; Boudjema, K.; Vaillant, J.C.; Balladur, P.; Nordlinger, B. Long-term survival following resection of colorectal hepatic metastases. Br. J. Surg. 1997, 84 (7), 977-980.
103. Adson, M.A.; van Heerden, J.A.; Adson, M.H.; Wagner, J.S.; Ilstrup, D.M. Resection of hepatic metastases from colorectal cancer. Arch. Surg. 1984, 119 (6), 647-651.
104. Hughes, K.S.; Simon, R.; Songhorabodi, S.; Adson, M.A.; Ilstrup, D.M.; Fortner, J.G.; Maclean, B.J.; Foster, J.H.; Daly, J.M.; Fitzherbert, D. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986, 100 (2), 278-284.
105. Rosen, C.B.; Nagorney, D.M.; Taswell, H.F.; Helgeson, S.L.; Ilstrup, D.M.; van Heerden, J.A.; Adson, M.A. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann. Surg. 1992, 216 (4), 493-504.
106. Fortner, J.G.; Silva, J.S.; Golbey, R.B.; Cox, E.B.; Maclean, B.J. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann. Surg. 1984, 199 (3), 306-316.
107. Fegiz, G.; Ramacciato, G.; Gennari, L.; Doci, R.; Pezzuoli, G.; Leggeri, A.; Peracchia, A.; Montorsi, W.; D'Angelo, F.; Aurello, P. Hepatic resections for colorectal metastases: the Italian multicenter experience. J. Surg. Oncol., Suppl. 1991, 2, 144-154.
108. Vogt, P.; Raab, R.; Ringe, B.; Pichlmayr, R. Resection of synchronous liver metastases from colorectal cancer. World J. Surg. 1991, 15 (1), 62-67.
109. Nakamura, S.; Yokoi, Y.; Suzuki, S.; Baba, S.; Muro, H. Results of extensive surgery for liver metastases in colorectal carcinoma. Br. J. Surg. 1992, 79 (1), 35-38.
110. Younes, R.N.; Rogatko, A.; Brennan, M.F. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann. Surg. 1991, 214 (2), 107-113.
111. Moertel, C.G.; Fleming, T.R.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A.; Goodman, P.J.; Ungerleider, J.S.; Emerson, W.A.; Tormey, D.C.; Glick, J.H. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med. 1990, 322 (6), 352-358.
112. Moertel, C.G. Chemotherapy for colorectal cancer. N. Engl. J. Med. 1994, 330 (16), 1136-1142.
113. Kemeny, N.; Gonen, M.; Sullivan, D.; Schwartz, L.; Benedetti, F.; Saltz, L.; Stockman, J.; Fong, Y.; Jarnagin, W.; Bertino, J.; Tong, W.; Paty, P. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J. Clin. Oncol. 2001, 19 (10), 2687-2695.
114. Que, F.G.; Nagorney, D.M.; Batts, K.P.; Linz, L.J.; Kvols, L.K. Hepatic resection for metastatic neuroendocrine carcinomas. Am. J. Surg. 1995, 169 (1), 36-42.
115. Chamberlain, R.S.; Canes, D.; Brown, K.T.; Saltz, L.; Jarnagin, W.; Fong, Y.; Blumgart, L.H. Hepatic neuroendocrine metastases: does intervention alter outcomes? J. Am. Coll. Surg. 2000, 190 (4), 432-445.
116. McCarter, M.D.; Fong, Y. Metastatic liver tumors. Semin. Surg. Oncol. 2000, 19 (2), 177-188.
117. Harrison, L.E.; Brennan, M.F.; Newman, E.; Fortner, J.G.; Picardo, A.; Blumgart, L.H.; Fong, Y. Hepatic resection for noncolorectal, nonneuro-endocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 1997, 121 (6), 625-632.
118. Elias, D.; Cavalcanti, D.A.; Eggenspieler, P.; Plaud, B.; Ducreux, M.; Spielmann, M.; Theodore, C.; Bonvalot, S.; Lasser, P. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J. Am. Coll. Surg. 1998, 187 (5), 487-493.
119. DeMatteo, R.P.; Shah, A.; Fong, Y.; Jarnagin, W.R.; Blumgart, L.H.; Brennan, M.F. Results of hepatic resection for sarcoma metastatic to liver. Ann. Surg. 2001, 234 (4), 540-547.
120. Elias, D.; Lasser, P.H.; Montrucolli, D.; Bonvallot, S.; Spielmann, M. Hepatectomy for liver metastases from breast cancer. Eur. J. Surg. Oncol. 1995, 21 (5), 510-513.
121. Okuda, K.; Ohtsuki, T.; Obata, H.; Tomimatsu, M.; Okazaki, N.; Hasegawa, H.; Nakajima, Y.; Ohnishi, K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985, 56 (4), 918-928.
122. Liver (including intrahepatic bile duct). In AJCC Cancer Staging Handbook; Fleming, I., Cooper, J., Henson, D., Hutter, R., Kennedy, B., Murphy, G., O'Sullivan, B., Sobin, L., Yarbro, J., Eds.; Lippincott-Raven: Philadelphia, 1998; 93-100.
123. Ebara, M.; Hatano, R.; Fukuda, H.; Yoshikawa, M.; Sugiura, N.; Saisho, H. Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients. Hepatogastroenterology 1998, 45 (Suppl. 3), 1214-1220.
124. Muto, Y.; Moriwaki, H.; Ninomiya, M.; Adachi, S.; Saito, A.; Takasaki, K.T.; Tanaka, T.; Tsurumi, K.; Okuno, M.; Tomita, E.; Nakamura, T.; Kojima, T. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N. Engl. J. Med. 1996, 334 (24), 1561-1567.
125. Lau, W.Y.; Leung, T.W.; Ho, S.K.; Chan, M.; Machin, D.; Lau, J.; Chan, A.T.; Yeo, W.; Mok, T.S.; Yu, S.C.; Leung, N.W.; Johnson, P.J. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 1999, 353 (9155), 797-801.
126. Morino, M.; Miglietta, C.; Grosso, M.; De Giuli, M.; Bismuth, H. Preoperative chemoembolization for hepatocellular carcinoma. J. Surg. Oncol., Suppl. 1993, 3, 91-93.
127. Majno, P.E.; Adam, R.; Bismuth, H.; Castaing, D.; Ariche, A.; Krissat, J.; Perrin, H.; Azoulay, D. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann. Surg. 1997, 226 (6), 688-701.
128. Li, J.Q.; Zhang, Y.Q.; Zhang, W.Z.; Yuan, Y.F.; Li, G.H. Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy. J. Cancer Res. Clin. Oncol. 1995, 121 (6), 364-366.
129. Harada, T.; Matsuo, K.; Inoue, T.; Tamesue, S.; Inoue, T.; Nakamura, H. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann. Surg, 1996, 224 (1), 4-9.
130. Yokoyama, I.; Todo, S.; Iwatsuki, S.; Starzl, T.E. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 1990, 37 (2), 188-193.
131. Haug, C.E.; Jenkins, R.L.; Rohrer, R.J.; Auchincloss, H.; Delmonico, F.L.; Freeman, R.B.; Lewis, W.D.; Cosimi, A.B. Liver transplantation for primary hepatic cancer. Transplantation 1992, 53 (2), 376-382.
132. Penn, I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991, 110 (4), 726-734.
133. Llovet, J.M.; Fuster, J.; Bruix, J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999, 30 (6), 1434-1440.
134. Kamath, P.S.; Wiesner, R.H.; Malinchoc, M.; Kremers, W.; Therneau, T.M.; Kosberg, C.L.; D'Amico, G.; Dickson, E.R.; Kim, W.R. A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33 (2), 464-470.
135. Brown, R.S., Jr.; Kumar, K.S.; Russo, M.W.; Kinkhabwala, M.; Rudow, D.L. ; Harren, P.; Lobritto, S.; Emond, J.C. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in united network for organ sharing status 2A patients. Liver Transplant. 2002, 8 (3), 278-284.
136. Emond, J.C.; Leib, M. The living-related liver transplant evaluation: linking risk factors and outcome. Liver Transplant. Surg. 1996, 2 (5 Suppl. 1), 57-63.
137. Wadstrom, J.; Rogiers, X.; Malago, M.; Fischer, L.; Langwieler, T.E.; Pollock, S.; Latta, A.; Burdelski, M.; Broelsch, C.E. Experience from the first 30 living related liver transplant in Hamburg. Transplant. Proc. 1995, 27 (1), 1173.
138. Fong, Y.; Cohen, A.M.; Fortner, J.G.; Enker, W.E.; Turnbull, A.D.; Coit, D.G.; Marrero, A.M.; Prasad, M.; Blumgart, L.H.; Brennan, M.F. Liver resection for colorectal metastases. J. Clin. Oncol. 1997, 15 (3), 938-946.
139. Scheele, J.; Stangl, R.; Altendorf-Hofmann, A.; Gall, F.P. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991, 110 (1), 13-29.
140. Schlag, P.; Hohenberger, P.; Herfarth, C. Resection of liver metastases in colorectal cancer-competitive analysis of treatment results in synchronous versus metachronous metastases. Eur. J. Surg. Oncol. 1990, 16 (4), 360-365.
141. Llovet, J.M.; Real, M.I.; Montana, X.; Planas, R.; Coll, S.; Aponte, J.; Ayuso, C.; Sala, M.; Muchart, J.; Sola, R.; Rodes, J.; Bruix, J. Barcelona Liver Cancer Group. Arterial embolisation of chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002, 359 (9319), 1734-1739.
142. Poon, R.T.; Fan, S.T.; Tsang, F.H.; Wong, J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann. Surg. 2002, 235 (4), 466-486.
143. Ravikumar, T.S.; Steele, G., Jr.; Kane, R.; King, V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res. 1991, 51 (23 Pt. 1), 6323-6327.
144. Ravikumar, T.S.; Kane, R.; Cady, B.; Jenkins, R.; Clouse, M.; Steele, G., Jr. A 5-year study of cryosurgery in the treatment of liver tumors. Arch. Surg. 1991, 126 (12), 1520-1523.
145. Morris, D.L.; Ross, W.B. Australian experience of cryoablation of liver tumors: metastases. Surg. Oncol. Clin. N. Am. 1996, 5 (2), 391-397.
146. Nagata, Y.; Hiraoka, M.; Akuta, K.; Abe, M.; Takahashi, M.; Jo, S.; Nishimura, Y.; Masunaga, S.; Fukuda, M.; Imura, H. Radiofrequency thermotherapy for malignant liver tumors. Cancer 1990, 65 (8), 1730-1736.
147. Allgaier, H.P.; Deibert, P.; Zuber, I.; Olschewski, M.; Blum, H.E. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 1999, 353 (9165), 1676-1677.
148. Izzo, F.; Barnett, C.C., Jr.; Curley, S.A. Radiofrequency ablation of primary and metastatic malignant liver tumors. Adv. Surg. 2001, 35, 225-250.
149. Parikh, A.A.; Curley, S.A.; Fornage, B.D.; Ellis, L.M. Radiofrequency ablation of hepatic metastases. Semin. Oncol. 2002, 29 (2), 168-182.
150. Choti, M.A.; Sitzmann, J.V.; Tiburi, M.F.; Sumetchotimetha, W.; Rangsin, R.; Schulick, R.D.; Lillemoe, K.D.; Yeo, C.J.; Cameron, J.L. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann. Surg, 2002, 235 (6), 759-766.
151. Ringe, B.; Pichlmayr, R.; Wittekind, C.; Tusch, G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J. Surg. 1991, 15 (2), 270-285.
152. Sasaki, Y.; Imaoka, S.; Masutani, S.; Ohashi, I.; Ishikawa, O.; Koyama, H.; Iwanaga, T. Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 1992, 112 (3), 515-521.
153. Nagasue, N.; Kohno, H.; Chang, Y.C.; Taniura, H.; Yamanoi, A.; Uchida, M.; Kimoto, T.; Takemoto, Y.; Nakamura, T.; Yukaya, H. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann. Surg. 1993, 217 (4), 375-384.
154. Takenaka, K.; Shimada, M.; Higashi, H.; Adachi, E.; Nishizaki, T.; Yanaga, K.; Matsumata, T.; Ikeda, T.; Sugimachi, K. Liver resection for hepatocellular carcinoma in the elderly. Arch. Surg. 1994, 129 (8), 846-850.
155. Suenaga, M.; Sugiura, H.; Kokuba, Y.; Uehara, S.; Kurumiya, T. Repeated hepatic resection for recurrent hepatocellular carcinoma in eighteen cases. Surgery 1994, 115 (4), 452-457.
156. Lai, E.C.; Fan, S.T.; Lo, C.M.; Chu, K.M.; Liu, C.L.; Wong, J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann. Surg. 1995, 221 (3), 291-298.
157. Vauthey, J.N.; Klimstra, D.; Franceschi, D.; Tao, Y.; Fortner, J.; Blumgart, L.; Brennan, M. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am. J. Surg. 1995, 169 (1), 28-34.
158. Takenaka, K.; Kawahara, N.; Yamamoto, K.; Kajiyama, K.; Maeda, T.; Itasaka, H.; Shirabe, K.; Nishizaki, T.; Yanaga, K.; Sugimachi, K. Results of 280 liver resections for hepatocellular carcinoma. Arch. Surg. 1996, 131 (1), 71-76.
159. Zhou, X.D.; Tang, Z.Y.; Yang, B.H.; Lin, Z.Y.; Ma, Z.C.; Ye, S.L.; Wu, Z.Q.; Fan, J.; Qin, L.X.; Zheng, B.H. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001, 91 (8), 1479-1486.